Bronchoscopic Ablation Therapy for Lung Malignancies

Transbronchial therapies for lung malignancies are relatively new in healthcare. This webinar is intended to improve knowledge of the role of bronchoscopic ablative treatments and their benefits and limitations for lung malignancies and gain insight into future developments in this rapidly growing therapeutic approach. Dr. Calvin SH Ng, BSc, MD, FRCS(C), FCCP (Hong Kong) will moderate and lead the discussion and Q&A following presentations by Agathe Seguin-Givelet, MD, Ph.D. (France), and Michael Pritchett, DO, MPH (USA). 

Learning Objectives:

At the end of the webinar, learners will be able to:

1. Examine forms of transbronchial therapies for lung malignancies, including available platforms for delivery.
2. Differentiate current evidence of the advantages or challenges of transbronchial therapeutic options.
3. Evaluate how to develop a clinical infostructure to support performing transbronchial therapeutic procedures as an option for patients.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.

The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.